Cannabis stocks were flat as a pancake on Wednesday on the back of a lacklustre week for cannabis stocks across North American markets.
The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, inched down 0.1% to close at 282.4 points. The Horizons Marijuana Life Sciences Index ETF was up 0.2% at C$20.59.
ICC International Cannabis Corp (CSE:WRLD.U) (OTCMKTS:WLDCF) shares soared earlier on Wednesday after it announced that it has entered into an agreement with Organic Flower Investment Groups Inc to access distribution in the European market.
Shares jumped up 8.1% at US$0.28 in New York, up 3.8% at C$0.27 in Toronto. In the afternoon, shares were halted, pending news.
International Cannabis will allow Organic Flower access to its European distribution network, which comprises 80,000 retail locations and pharmacies across the continent, and commercial rights for cannabis processing and finishing at ICC’s GMP-certified facilities.
READ: ICC International Cannabis strikes exclusive distribution deal with Organic Flower for access to its European retail network
The company hasn't released any news, however, it is currently undergoing an audit of its 2018 financial statements.
True Leaf Medicine International Ltd (CSE:MJ) (OTCMKTS:TRLFF) shares were up 4.3% at C$0.49 in Toronto. The Vernon, BC-based cannabis and hemp wellness brand for pets announced earlier this week that it had appointed an executive from the world's largest pet food company to lead its pet division.
Kevin Cole, a former vice president of marketing at Mars Petcare, joins the cannabis for pets brand as president of True Leaf Pet.
The firm announced it was spending US$32.6 milliong to increase the company’s Canadian cannabis production and manufacturing footprint by 203,000 square feet across three facilities: Leamington, Ontario, London, Ontario, and Nanaimo, British Columbia.
Aleafia Health Inc (TSE:ALEF) (OTCMKTS:ALEAF) shares dropped sharply after gains earlier this week. Shares were down 2.9% at C$1.66 in Toronto, off 3% at US$1.24 in New York.
Earlier this week the company announced it was entering the German medical cannabis market via its joint-venture with German pharmaceutical wholesaler Acnos Pharma GmbH.
--updates share prices--
Contact Katie Lewis at [email protected]
Follow her on Twitter @kelewis